This study demonstrated that Phyduxon-T has the potential to initiate TAA-specific CD8 T cell responses and execute T-dependent tumoricidal activities in vitro. However, limitations arise from the suppressive tumor microenvironments, hindering the migration and infiltration of TAA-specific CD8 T cells and their corresponding cytotoxicity against cancer [45]. The gene discussed is CD8A; the disease is cancer.